Skip to content

Men With Fibromyalgia or Chronic Widespread Pain - Effect of Exercise on Symptoms and Body Functions

Men With Fibromyalgia or Chronic Widespread Pain - Effect of Exercise on Symptoms and Body Functions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01278641
Enrollment
44
Registered
2011-01-19
Start date
2008-01-31
Completion date
2009-11-30
Last updated
2011-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Pain

Keywords

Fibromyalgia, Widespread pain, Fatigue, Physical exercise

Brief summary

A controlled randomised trial (CRT). 60 men who fulfil the ACR-criteria for Fibromyalgia or Chronic Widespread Pain (Wolfe 1990) participate in the study. The main objective of the study is to compare the effect of a graded strength training program and a low intensive pool exercise program.

Detailed description

A controlled randomised trial (CRT). 60 men who fulfil the ACR-criteria for Fibromyalgia or Chronic Widespread Pain (Wolfe 1990) participate in the study. 40 patients (in the city Uddevalla) are randomised into two groups; low intensive temperate pool exercise program, and graded strength training program. The study period is 12 weeks. 20 patients (in the city Alingsås) make a reference group who is asked to continue their normal activities during the study period. Primary outcomes are fatigue (using the Multidimensional fatigue inventory and VAS for global fatigue)and muscle strength (using Steve Strong, Isobex and the Grippit). Several other self-administered instruments was used.

Interventions

BEHAVIORALGraded strength resistance training program

Graded strength resistance training, 75 minutes, twice a week for 12 weeks.

BEHAVIORALTemperate pool exercise program

Temperate pool low intensive exercise, 50 minutes, twice a week for 12 weeks.

Sponsors

Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Male patients with Fibromyalgia or Chronic Widespread pain

Exclusion criteria

Other severe physical or psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
The multidimensional Fatigue Inventory (MFI-20)12 weeks

Secondary

MeasureTime frame
The Hospital Anxiety and Depression Scale (HADS)12 weeks
Muscle strength (measured with Isobex and Steve Strong)12 weeks

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026